Workflow
a
icon
搜索文档
Saga Communications, Inc. Announces Date and Time of 2nd Quarter Earnings Release and Conference Call
Globenewswire· 2025-07-10 04:05
GROSSE POINTE FARMS, Mich., July 09, 2025 (GLOBE NEWSWIRE) -- Saga Communications, Inc. (Nasdaq: SGA) announced today that it will release its 2nd Quarter 2025 results at 9:00 a.m. EDT on Thursday, August 7, 2025. The company will be holding a conference call on the same date at 11:00 a.m. EDT. The dial-in numbers are as follows: Domestic and International Dial-in Number: (973) 528-0008 Conference Entry Code: 739704 The Company requests that all parties that have a question that they would like to submit t ...
Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis
Globenewswire· 2025-07-10 04:05
Data from Orbit and Cosmic studies expected around the end of the yearNOVATO, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO), today announced that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in pediatric and young adult patients with osteogenesis imperfecta (OI) is progressing toward a final analysis consistent with the original plan, around the end of the year. The D ...
Duolingo to Announce Second Quarter 2025 Results on Wednesday August 6, 2025
Globenewswire· 2025-07-10 04:05
About Duolingo PITTSBURGH, July 09, 2025 (GLOBE NEWSWIRE) -- Duolingo, Inc. (Nasdaq: DUOL), the world's leading mobile learning platform, will announce its results for the second quarter ending June 30, 2025, following the close of the U.S. market on Wednesday, August 6, 2025. The Company will host a video webcast at 5:30 p.m. ET on that day. The live video webcast will be accessible to the public through Duolingo's Investor Relations website at https://investors.duolingo.com. A replay of the event will be ...
After a 246% Rally, Is Navitas Semiconductor a Buy or a Hold in 2025?
ZACKS· 2025-07-10 04:01
Key Takeaways Navitas Semiconductor (NVTS) has delivered a standout performance in 2025, with its stock skyrocketing 246% over the past three months, far outpacing the broader Electronics - Semiconductors industry, the Computer and Technology sector and benchmark indices like the S&P 500. The rally has also outpaced the broader PHLX Semiconductor Index's (SOX) 58.3% growth. While revenue growth remains modest, investor enthusiasm is fueled by Navitas' expanding customer pipeline, new design wins and growing ...
AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for July 2025
Prnewswire· 2025-07-10 04:01
BETHESDA, Md., July 9, 2025 /PRNewswire/ -- AGNC Investment Corp. (Nasdaq: AGNC) announced today that its Board of Directors has declared a cash dividend of $0.12 per share of common stock for July 2025. The dividend is payable on August 11, 2025 to common stockholders of record as of July 31, 2025. For further information or questions, please contact Investor Relations at (301) 968-9300 or [email protected]. ABOUT AGNC INVESTMENT CORP. Founded in 2008, AGNC Investment Corp. (Nasdaq: AGNC) is a leading inve ...
Nurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
Globenewswire· 2025-07-10 04:01
Presented updated data for bexobrutideg (NX-5948) at EHA2025 and ICML-18, demonstrating a favorable safety profile and deepening responses in patients with r/r chronic lymphocytic leukemia (CLL) and Waldenström macroglobulinemia (WM) Secured $15M license fee as Sanofi extends STAT6 collaboration to target type 2 inflammatory diseases Announced FDA clearance of IND application for novel IRAK4 degrader GS-6791/NX-0479, enabling collaboration partner Gilead to initiate Phase 1 trial Well capitalized with cash ...
Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine
Globenewswire· 2025-07-10 04:01
The previously disclosed and now published RESILIENT data show that once-nightly TNX-102 SL achieved statistically significant improvement in the primary endpoint of reducing fibromyalgia pain versus placebo, and was generally well tolerated These results confirm findings from the previously published RELIEF phase 3 trial, which also demonstrated a statistically significant reduction in fibromyalgia pain FDA target PDUFA date for TNX-102 SL is August 15, 2025 and, if approved, would be the first new drug fo ...
OpenAI即将推出AI浏览器 直接挑战谷歌Chrome霸主地位
华尔街见闻· 2025-07-10 04:00
OpenAI即将推出AI浏览器,旨在利用人工智能技术从根本上改变消费者的网络浏览方式,直接挑战占 据市场主导地位的谷歌Chrome。 报道指出,OpenAI浏览器最大特色,是让用户在ChatGPT式本地界面完成部分交互,减少传统跳转网站 的行为。同时,浏览器将深度整合AI"代理人"(agent),可代表用户完成如预订、表单填写等操作。 此举旨在推动AI服务更深入个人与工作场景,加快AI与用户日常行为的天然融合。 7月9日据媒体报道,OpenAI的浏览器有望在未来数周内上线,集成聊天界面和AI代理功能。若能获得 其4亿每周活跃ChatGPT用户的拥护,OpenAI或将对谷歌广告生态、Web数据流和搜索流量产生实质 冲击。谷歌Chrome长期作为Alphabet广告业务的支柱,为广告精准投放和流量导向自有搜索引擎提供基 础数据。 AI驱动浏览器:重新定义互联网入口 OpenAI这款浏览器被认为将极大革新传统的网络浏览。 据报道,不同于仅作为插件存在的AI产品,其以AI能力为核心,将ChatGPT的交互体验与网页浏览无缝 结合。更重要的是,浏览器将作为AI"代理人"工作的理想平台。 用户不仅能基于对话式交互获取信息 ...
IRBT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that iRobot Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire News Room· 2025-07-10 04:00
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired iRobot securities between January 29, 2024 and March 11, 2025, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/IRBT. NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized ...
波场TRON创始人孙宇晨承诺购买1亿美元的特朗普币,称其为“MAGA货币”。
快讯· 2025-07-10 03:53
波场TRON创始人孙宇晨承诺购买1亿美元的特朗普币,称其为"MAGA货币"。 ...